Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $4.38 Million - $5.28 Million
16,276 New
16,276 $4.63 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $4.71 Million - $5.98 Million
-20,561 Reduced 93.78%
1,363 $357,000
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $1.61 Million - $1.82 Million
-7,193 Reduced 24.7%
21,924 $4.94 Million
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $5.78 Million - $6.44 Million
25,068 Added 619.12%
29,117 $7.08 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $887,824 - $982,165
4,049 New
4,049 $979,000
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $1.87 Million - $2.08 Million
-7,962 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $1.57 Million - $1.93 Million
7,962 New
7,962 $1.88 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $20.7 Million - $26.6 Million
-109,175 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $9.48 Million - $11.4 Million
54,450 Added 99.5%
109,175 $21.1 Million
Q2 2019

Jul 08, 2019

BUY
$166.7 - $195.41 $8.84 Million - $10.4 Million
53,033 Added 3134.34%
54,725 $10.1 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $31,471 - $35,475
174 Added 11.46%
1,692 $321,000
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $55,482 - $64,765
-311 Reduced 17.0%
1,518 $296,000
Q3 2018

Nov 02, 2018

SELL
$185.29 - $208.89 $126,367 - $142,462
-682 Reduced 27.16%
1,829 $0
Q2 2018

Aug 20, 2018

SELL
$166.05 - $186.51 $442,357 - $496,862
-2,664 Reduced 51.48%
2,511 $0
Q1 2018

May 21, 2018

BUY
$169.43 - $198.0 $121,311 - $141,768
716 Added 16.06%
5,175 $0
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $7.76 Million - $8.66 Million
-45,946 Reduced 91.15%
4,459 $775,000
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $4.9 Million - $5.59 Million
29,264 Added 138.42%
50,405 $9.4 Million
Q2 2017

Aug 17, 2017

BUY
N/A
21,141
21,141 $3.64 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $148B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.